Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 298


c-Abl mediates angiotensin II-induced apoptosis in podocytes.

Chen X, Ren Z, Liang W, Zha D, Liu Y, Chen C, Singhal PC, Ding G.

J Mol Histol. 2013 Oct;44(5):597-608. doi: 10.1007/s10735-013-9505-8. Epub 2013 Mar 21.


Angiotensin II induces nephrin dephosphorylation and podocyte injury: role of caveolin-1.

Ren Z, Liang W, Chen C, Yang H, Singhal PC, Ding G.

Cell Signal. 2012 Feb;24(2):443-50. doi: 10.1016/j.cellsig.2011.09.022. Epub 2011 Oct 1.


Angiotensin II down-regulates nephrin-Akt signaling and induces podocyte injury: roleof c-Abl.

Yang Q, Ma Y, Liu Y, Liang W, Chen X, Ren Z, Wang H, Singhal PC, Ding G.

Mol Biol Cell. 2016 Jan 1;27(1):197-208. doi: 10.1091/mbc.E15-04-0223. Epub 2015 Oct 28.


c-Abl contributes to glucose-promoted apoptosis via p53 signaling pathway in podocytes.

Ma Y, Yang Q, Chen X, Liang W, Ren Z, Ding G.

Diabetes Res Clin Pract. 2016 Mar;113:171-8. doi: 10.1016/j.diabres.2015.12.013. Epub 2016 Jan 13.


Calmodulin-dependent protein kinase II/cAMP response element-binding protein/Wnt/β-catenin signaling cascade regulates angiotensin II-induced podocyte injury and albuminuria.

Jiang L, Xu L, Song Y, Li J, Mao J, Zhao AZ, He W, Yang J, Dai C.

J Biol Chem. 2013 Aug 9;288(32):23368-79. doi: 10.1074/jbc.M113.460394. Epub 2013 Jun 26.


IQGAP1 mediates angiotensin II-induced apoptosis of podocytes via the ERK1/2 MAPK signaling pathway.

Liu Y, Liang W, Yang Q, Ren Z, Chen X, Zha D, Singhal PC, Ding G.

Am J Nephrol. 2013;38(5):430-44. doi: 10.1159/000355970. Epub 2013 Nov 12.


Angiotensin II infusion induces nephrin expression changes and podocyte apoptosis.

Jia J, Ding G, Zhu J, Chen C, Liang W, Franki N, Singhal PC.

Am J Nephrol. 2008;28(3):500-7. doi: 10.1159/000113538. Epub 2008 Jan 17.


Antiangiogenic treatment diminishes renal injury and dysfunction via regulation of local AKT in early experimental diabetes.

Bai X, Li X, Tian J, Zhou Z.

PLoS One. 2014 Apr 23;9(4):e96117. doi: 10.1371/journal.pone.0096117. eCollection 2014. Erratum in: PLoS One. 2014;9(7):e103926.


Effect of the knockdown of Cabin1 on p53 in glomerular podocyte.

Wen Y, Zhou P, Liu L, Wang Z, Zhang Y, Liang J.

J Recept Signal Transduct Res. 2016;36(2):173-80. doi: 10.3109/10799893.2015.1069847. Epub 2015 Sep 23.


Angiotensin II Modulates p130Cas of Podocytes by the Suppression of AMP-Activated Protein Kinase.

Ha TS, Park HY, Seong SB, Ahn HY.

J Korean Med Sci. 2016 Apr;31(4):535-41. doi: 10.3346/jkms.2016.31.4.535. Epub 2016 Mar 2.


Influence of tacrolimus on podocyte injury inducted by angiotensin II.

Shengyou Y, Li Y, Zhihong H, Yuanyuan M.

J Renin Angiotensin Aldosterone Syst. 2015 Jun;16(2):260-6. doi: 10.1177/1470320314568520. Epub 2015 Feb 3.


Inhibition of c-Abl kinase activity renders cancer cells highly sensitive to mitoxantrone.

Alpay K, Farshchian M, Tuomela J, Sandholm J, Aittokallio K, Siljamäki E, Kallio M, Kähäri VM, Hietanen S.

PLoS One. 2014 Aug 22;9(8):e105526. doi: 10.1371/journal.pone.0105526. eCollection 2014.


Angiotensin II induces reorganization of the actin cytoskeleton and myosin light-chain phosphorylation in podocytes through rho/ROCK-signaling pathway.

Wang S, Chen C, Su K, Zha D, Liang W, Hillebrands JL, Goor Hv, Ding G.

Ren Fail. 2016;38(2):268-75. doi: 10.3109/0886022X.2015.1117896. Epub 2015 Dec 10.


Role of CD2-associated protein in albumin overload-induced apoptosis in podocytes.

He FF, Zhang C, Chen S, Deng BQ, Wang H, Shao N, Tian XJ, Fang Z, Sun XF, Liu JS, Zhu ZH, Meng XF.

Cell Biol Int. 2011 Aug;35(8):827-34. doi: 10.1042/CBI20100411.


Enhanced glycogen synthase kinase-3β activity mediates podocyte apoptosis under diabetic conditions.

Paeng J, Chang JH, Lee SH, Nam BY, Kang HY, Kim S, Oh HJ, Park JT, Han SH, Yoo TH, Kang SW.

Apoptosis. 2014 Dec;19(12):1678-90. doi: 10.1007/s10495-014-1037-5.


Downregulation of the antioxidant protein peroxiredoxin 2 contributes to angiotensin II-mediated podocyte apoptosis.

Hsu HH, Hoffmann S, Di Marco GS, Endlich N, Peter-Katalinić J, Weide T, Pavenstädt H.

Kidney Int. 2011 Nov;80(9):959-69. doi: 10.1038/ki.2011.250. Epub 2011 Aug 3.


C-Abl inhibitor imatinib enhances insulin production by β cells: c-Abl negatively regulates insulin production via interfering with the expression of NKx2.2 and GLUT-2.

Xia CQ, Zhang P, Li S, Yuan L, Xia T, Xie C, Clare-Salzler MJ.

PLoS One. 2014 May 16;9(5):e97694. doi: 10.1371/journal.pone.0097694. eCollection 2014.


Mechanisms of angiotensin II signaling on cytoskeleton of podocytes.

Hsu HH, Hoffmann S, Endlich N, Velic A, Schwab A, Weide T, Schlatter E, Pavenstädt H.

J Mol Med (Berl). 2008 Dec;86(12):1379-94. doi: 10.1007/s00109-008-0399-y. Epub 2008 Sep 5.


Genetic disruption of Abl nuclear import reduces renal apoptosis in a mouse model of cisplatin-induced nephrotoxicity.

Sridevi P, Nhiayi MK, Wang JY.

Cell Death Differ. 2013 Jul;20(7):953-62. doi: 10.1038/cdd.2013.42. Epub 2013 May 10.


Ginsenoside Rg1 inhibits angiotensin II-induced podocyte autophagy via AMPK/mTOR/PI3K pathway.

Mao N, Tan RZ, Wang SQ, Wei C, Shi XL, Fan JM, Wang L.

Cell Biol Int. 2016 Aug;40(8):917-25. doi: 10.1002/cbin.10634. Epub 2016 Jun 28.


Supplemental Content

Support Center